SER (STOCKS)
Serina Therapeutics, Inc.
$2.640000
-0.180000 (-6.38%)
Prev close: $2.820000
Company Information
- Exchange
- XASE
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- CEO
- Steven A. Ledger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $57.38M
- Employees
- 13
- P/E (TTM)
- -1.43
- P/B (TTM)
- 3.31
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.58 | $-0.44 | -0.1356 | -30.51% |
|
Dec 2025 (Q4)
|
$-0.31 | $-0.46 | +0.1546 | +33.28% |
|
Sep 2025 (Q3)
|
$-0.51 | $-0.54 | +0.0253 | +4.73% |
|
Jun 2025 (Q2)
|
$-0.66 | $-0.43 | -0.2307 | -53.74% |
Financial Statements
| Nonoperating Income/Loss | $3.18M |
| Operating Expenses | $24.57M |
| Depreciation and Amortization | $74.00K |
| Research and Development | $13.40M |
| Other Operating Expenses | $11.13M |
| Income/Loss From Continuing Operations After Tax | -$21.29M |
| Income/Loss From Continuing Operations Before Tax | -$21.27M |
| Income Tax Expense/Benefit | $25.00K |
| Net Income/Loss | -$21.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$24.00K |
| Net Income/Loss Attributable To Parent | -$21.27M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $175.00K |
| Preferred Stock Dividends And Other Adjustments | $175.00K |
| Basic Earnings Per Share | -$2.00 |
| Diluted Earnings Per Share | -$2.00 |
| Basic Average Shares | 32,548,000 |
| Diluted Average Shares | 32,548,000 |
| Assets | $27.30M |
| Current Assets | $26.47M |
| Noncurrent Assets | $825.00K |
| Fixed Assets | $472.00K |
| Other Non-current Assets | $353.00K |
| Liabilities | $9.67M |
| Current Liabilities | $6.34M |
| Accounts Payable | $2.83M |
| Other Current Liabilities | $3.51M |
| Noncurrent Liabilities | $3.33M |
| Equity | $17.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $17.63M |
| Liabilities And Equity | $27.30M |
| Net Cash Flow From Operating Activities | -$18.20M |
| Net Cash Flow From Operating Activities, Continuing | -$18.20M |
| Net Cash Flow From Investing Activities | $511.00K |
| Net Cash Flow From Investing Activities, Continuing | $511.00K |
| Net Cash Flow From Financing Activities | $38.55M |
| Net Cash Flow From Financing Activities, Continuing | $38.55M |
| Net Cash Flow | $20.86M |
| Net Cash Flow, Continuing | $20.86M |
| Comprehensive Income/Loss | -$21.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$10.00K |
| Comprehensive Income/Loss Attributable To Parent | -$21.29M |
| Other Comprehensive Income/Loss | -$8.00K |